Jang Ji Woong, Kim Myung-Hwan, Oh Dongwook, Cho Dong Hui, Song Tae Jun, Park Do Hyun, Lee Sang Soo, Seo Dong-Wan, Lee Sung Koo, Moon Sung-Hoon
Department of Internal Medicine, Eulji University College of Medicine, Eulji University Hospital, Daejeon, South Korea.
Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Pancreatology. 2016 Nov-Dec;16(6):958-965. doi: 10.1016/j.pan.2016.09.009. Epub 2016 Sep 20.
Acute necrotizing pancreatitis (ANP) can affect main pancreatic duct (MPD) as well as parenchyma. However, the incidence and outcomes of MPD disruption has not been well studied in the setting of ANP.
This retrospective study investigated 84 of 465 patients with ANP who underwent magnetic resonance cholangiopancreatography and/or endoscopic retrograde cholangiopancreatography. The MPD disruption group was subclassified into complete and partial disruption.
MPD disruption was documented in 38% (32/84) of the ANP patients. Extensive necrosis, enlarging/refractory pancreatic fluid collections (PFCs), persistence of amylase-rich output from percutaneous drainage, and amylase-rich ascites/pleural effusion were more frequently associated with MPD disruption. Hospital stay was prolonged (mean 55 vs. 29 days) and recurrence of PFCs (41% vs. 14%) was more frequent in the MPD disruption group, although mortality did not differ between ANP patients with and without MPD disruption. Subgroup analysis between complete disruption (n = 14) and partial disruption (n = 18) revealed a more frequent association of extensive necrosis and full-thickness glandular necrosis with complete disruption. The success rate of endoscopic transpapillary pancreatic stenting across the stricture site was lower in complete disruption (20% vs. 92%). Patients with complete MPD disruption also showed a high rate of PFC recurrence (71% vs. 17%) and required surgery more often (43% vs. 6%).
MPD disruption is not uncommon in patients with ANP with clinical suspicion on ductal disruption. Associated MPD disruption may influence morbidity, but not mortality of patients with ANP. Complete MPD disruption is often treated by surgery, whereas partial MPD disruption can be managed successfully with endoscopic transpapillary stenting and/or transmural drainage. Further prospective studies are needed to study these items.
急性坏死性胰腺炎(ANP)可累及主胰管(MPD)及实质。然而,在ANP背景下,MPD中断的发生率及预后尚未得到充分研究。
本回顾性研究调查了465例接受磁共振胰胆管造影和/或内镜逆行胰胆管造影的ANP患者中的84例。MPD中断组又细分为完全中断和部分中断。
84例ANP患者中有38%(32/84)记录有MPD中断。广泛坏死、不断增大/难治性胰液积聚(PFC)、经皮引流持续引出富含淀粉酶的液体以及富含淀粉酶的腹水/胸腔积液与MPD中断的相关性更高。MPD中断组的住院时间延长(平均55天对29天),PFC复发更频繁(41%对14%),尽管有或无MPD中断的ANP患者死亡率无差异。完全中断(n = 14)和部分中断(n = 18)的亚组分析显示,广泛坏死和全层腺泡坏死与完全中断的相关性更高。完全中断时,内镜下经乳头胰管支架置入穿过狭窄部位的成功率较低(20%对92%)。MPD完全中断的患者PFC复发率也较高(71%对17%),且更常需要手术(43%对6%)。
在临床怀疑有导管中断的ANP患者中,MPD中断并不少见。相关的MPD中断可能影响ANP患者的发病率,但不影响死亡率。MPD完全中断常需手术治疗,而部分MPD中断可通过内镜下经乳头支架置入和/或经壁引流成功处理。需要进一步的前瞻性研究来研究这些问题。